Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001453687-21-000173

President and CEO acquired 37,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Brunn Carsten President and CEO 2021-12-08 Grant or award +37,500 322,451 D
Loading xslF345X03/wf-form4_163917398636442.xml…